Format

Send to

Choose Destination
N Engl J Med. 2007 Jul 19;357(3):258-65.

BCR-ABL tyrosine kinase inhibitors for chronic myelogenous leukemia.

Author information

1
Division of Hematology/Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201, USA. schiffer@karmanos.org
PMID:
17634461
DOI:
10.1056/NEJMct071828
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center